4.6 Review

Stemness of T cells and the hematopoietic stem cells: Fate, memory, niche, cytokines

Journal

CYTOKINE & GROWTH FACTOR REVIEWS
Volume 24, Issue 6, Pages 485-501

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2013.10.002

Keywords

Hematopoietic stem cells; T memory stem cells; T memory cells; Stem cell markers; Self renewal

Ask authors/readers for more resources

Stem cells are able to generate both cells that differentiate and cells that remain undifferentiated but potentially have the same developmental program. The prolonged duration of the protective immune memory for infectious diseases such as polio, small pox, and measles, suggested that memory T cells may have stem cell properties. Understanding the molecular basis for the life-long persistence of memory T cells may be useful to project targeted therapies for immune deficiencies and infectious diseases and to formulate vaccines. In the last decade evidence from different laboratories shows that memory T cells may share self-renewal pathways with bone marrow hematopoietic stem cells. In stem cells the intrinsic self-renewal activity, which depends on gene expression, is known to be modulated by extrinsic signals from the environment that may be tissue specific. These extrinsic signals for sternness of memory T cells include cytokines such as IL-7 and IL-15 and there are other cytokine signals for maintaining the cytokine signature (TH1, TH2, etc.) of memory T cells. Intrinsic and extrinsic pathways that might be common to bone marrow hematopoietic stem cells and memory T lymphocytes are discussed and related to self-renewal functions. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Postnatal development of the distribution of nitric oxide-producing neurons in the rat corpus callosum

Paolo Barbaresi, Emanuela Mensa, Andrea Sagrati, Laura Graciotti

NEUROSCIENCE RESEARCH (2020)

Article Oncology

New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models

Julie A. Hixon, Caroline Andrews, Lila Kashi, Casey L. Kohnhorst, Emilee Senkevitch, Kelli Czarra, Joao T. Barata, Wenqing Li, Joel P. Schneider, Scott T. R. Walsh, Scott K. Durum

LEUKEMIA (2020)

Article Cell Biology

Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells

Emanuela Mensa, Michele Guescini, Angelica Giuliani, Maria Giulia Bacalini, Deborah Ramini, Giacomo Corleone, Manuela Ferracin, Gianluca Fulgenzi, Laura Graciotti, Francesco Prattichizzo, Leonardo Sorci, Michela Battistelli, Vladia Monsurro, Anna Rita Bonfigli, Maurizio Cardelli, Rina Recchioni, Fiorella Marcheselli, Silvia Latini, Serena Maggio, Mirco Fanelli, Stefano Amatori, Gianluca Storci, Antonio Ceriello, Vilberto Stocchi, Maria De Luca, Luca Magnani, Maria Rita Rippo, Antonio Domenico Procopio, Claudia Sala, Iva Budimir, Cristian Bassi, Massimo Negrini, Paolo Garagnani, Claudio Franceschi, Jacopo Sabbatinelli, Massimiliano Bonafe, Fabiola Olivieri

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Article Endocrinology & Metabolism

Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes

Francesco Prattichizzo, Angelica Giuliani, Jacopo Sabbatinelli, Giulia Matacchione, Deborah Ramini, Anna Rita Bonfigli, Maria Rita Rippo, Paola de Candia, Antonio Domenico Procopio, Fabiola Olivieri, Antonio Ceriello

DIABETES OBESITY & METABOLISM (2020)

Article Immunology

Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis

Felix E. Y. Aggor, Timothy J. Break, Giraldina Trevejo-Nunez, Natasha Whibley, Bianca M. Coleman, Rachel D. Bailey, Daniel H. Kaplan, Julian R. Naglik, Wei Shan, Amol C. Shetty, Carrie McCracken, Scott K. Durum, Partha S. Biswas, Vincent M. Bruno, Jay K. Kolls, Michail S. Lionakis, Sarah L. Gaffen

SCIENCE IMMUNOLOGY (2020)

Article Endocrinology & Metabolism

CD31(+) Extracellular Vesicles From Patients With Type 2 Diabetes Shuttle a miRNA Signature Associated With Cardiovascular Complications

Francesco Prattichizzo, Valeria De Nigris, Jacopo Sabbatinelli, Angelica Giuliani, Carlos Castano, Marcelina Parrizas, Isabel Crespo, Annalisa Grimaldi, Nicolo Baranzini, Rosangela Spiga, Elettra Mancuso, Maria Rita Rippo, Antonio Domenico Procopio, Anna Novials, Anna Rita Bonfigli, Silvia Garavelli, Lucia La Sala, Giuseppe Matarese, Paola de Candia, Fabiola Olivieri, Antonio Ceriello

Summary: The study introduced a new method to isolate plasma CD31(+) EVs and identified certain miRNAs associated with vascular performance in T2DM patients, suggesting their potential role in T2DM and complications.

DIABETES (2021)

Article Cell Biology

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Jacopo Sabbatinelli, Angelica Giuliani, Giulia Matacchione, Silvia Latini, Noemi Laprovitera, Giovanni Pomponio, Alessia Ferrarini, Silvia Svegliati Baroni, Marianna Pavani, Marco Moretti, Armando Gabrielli, Antonio Domenico Procopio, Manuela Ferracin, Massimiliano Bonafe, Fabiola Olivieri

Summary: The expression levels of miR-146a-5p related to inflammaging changed in COVID-19 patients after receiving treatment with Tocilizumab, with patients who did not respond to the drug having lower levels of miR-146a-5p and experiencing worse outcomes. This blood-based biomarker may offer insights into the molecular link between inflammaging and the clinical course of COVID-19, providing a better understanding for using biologic drugs against this global health threat.

MECHANISMS OF AGEING AND DEVELOPMENT (2021)

Article Biochemistry & Molecular Biology

The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents

Angelica Giuliani, Alberto Montesanto, Giulia Matacchione, Laura Graciotti, Deborah Ramini, Olga Protic, Roberta Galeazzi, Roberto Antonicelli, Elena Tortato, Anna Rita Bonfigli, Jacopo Sabbatinelli, Fabiola Olivieri

Summary: Disorders of lipoprotein metabolism are associated with cardiovascular disease development. Certain SNPs in coding genes are associated with individual lipid profiles and response to lipid-lowering treatments. The rs3746444 SNP in the MIR499 gene is associated with a favorable blood lipid profile.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Trained ILC3 responses promote intestinal defense

Nicolas Serafini, Angelique Jarade, Laura Surace, Pedro Goncalves, Odile Sismeiro, Hugo Varet, Rachel Legendre, Jean-Yves Coppee, Olivier Disson, Scott K. Durum, Gad Frankel, James P. Di Santo

Summary: Group 3 innate lymphoid cells (ILC3s) in the intestine remain activated for months after exposure to Citrobacter rodentium, leading to enhanced immune response and defense capability. These trained ILC3s undergo metabolic changes and exhibit enhanced proliferative capacity and IL-22 production.

SCIENCE (2022)

Article Oncology

Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killing

Federica Monaco, Laura De Conti, Simone Vodret, Nunzia Zanotta, Manola Comar, Sandra Manzotti, Corrado Rubini, Laura Graciotti, Gianluca Fulgenzi, Massimo Bovenzi, Marco Baralle, Marco Tomasetti, Lory Santarelli

Summary: This study proposes a novel miRNA-based therapy approach to target malignant pleural mesothelioma (MPM) by increasing stemness and inhibiting cell proliferation. It is found that by inhibiting the release of exosomes, miR-126 can accumulate intracellularly and induce cell death and tumor growth arrest. Autophagy and necroptosis are involved in these processes, suggesting the potential of this therapy against cancer stem cells (CSCs).

TRANSLATIONAL ONCOLOGY (2022)

Article Biology

Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model

Daniel P. Brice, Graeme Murray, Heather M. Wilson, Ross J. Porter, Susan Berry, Scott K. Durum, Mairi H. McLean

Summary: This study demonstrates that interleukin-27 (IL-27) plays a crucial role in the function of gut epithelial barrier, restoring permeability, regulating immune responses, and promoting wound healing, suggesting its potential as a treatment strategy for inflammatory bowel disease (IBD).

BIOLOGY-BASEL (2022)

Biographical-Item Immunology

Joost J. Oppenheim (1934-2022)

Scott K. Durum

NATURE IMMUNOLOGY (2022)

Review Biochemistry & Molecular Biology

IL-7: Comprehensive review

Hila Winer, Gisele O. L. Rodrigues, Julie A. Hixon, Francesca B. Aiello, Tu Chun Hsu, Brianna T. Wachter, Wenqing Li, Scott K. Durum

Summary: IL-7 is a cytokine that plays a crucial role in the development and survival of lymphoid cells. It regulates cell functions through the IL-7 receptor signal transduction pathway. Abnormalities in the IL-7 pathway can lead to immunodeficiencies and autoimmune diseases. IL-7 has potential clinical applications in cancer treatment and autoimmune diseases.

CYTOKINE (2022)

Article Pharmacology & Pharmacy

SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy

M. Pesaresi, F. Pirani, A. Tagliabracci, M. Valsecchi, A. D. Procopio, F. P. Busardo, L. Graciotti

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2020)

No Data Available